Phio Pharmaceuticals finished its first big batch of PH-762, getting ready for the next trial.

Oct 13, 2026, 8:59 AM ETTrialRead the original at SEC EDGAR

Good for PHIO

Phio completed its first commercial-scale PH-762 drug batch, which supports its planned 2027 trial. The trial is still ahead, so this is progress toward testing, not proof the drug works.

PHIO · Phio Pharmaceuticals Corp.

AI read · Good for PHIO

The AI's read

This clears a manufacturing step for Phio's planned study. It says nothing about whether PH-762 helps patients. The study is still planned for 2027, so the positive news is preparation, not a result from patients.

Get alerts for PHIO

Follow Phio Pharmaceuticals Corp. (PHIO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PHIO

Free on the App Store and Google Play, or on the web.